Antibody‐Functionalized Hybrid Superparamagnetic Nanoparticles
Source abstract
Abstract
Abstract Superparamagnetic hybrid nanoparticles (ca. 80 nm) are obtained. They consist of an inner iron oxide core coated by a silica shell, which is in turn functionalized with amine or carboxyl groups and covalently coupled to a monoclonal antibody (anti‐hCG; hCG = human chorionic gonadotropin). The prepared nanoparticles show a specific magnetic moment (per gram of iron) that is comparable to that measured for commercial superparamagnetic iron oxide preparations. The bioactivity of the antibody‐conjugated magnetic nanoparticles is verified by a standard bioassay. These results indicate the potential of the hybrid nanoparticles prepared for use as enhanced contrast agents in magnetic resonance imaging applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Iron oxide chemistry and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. 10.1093/annonc/mdi09810.1093/annonc/mdi098 ↗
2. 10.1016/j.addr.2005.01.02110.1016/j.addr.2005.01.021 ↗
3. 10.1016/j.addr.2005.01.02410.1016/j.addr.2005.01.024 ↗
4. 10.1016/S0169-409X(98)00103-310.1016/S0169-409X(98)00103-3 ↗
5. 10.1016/S0720-048X(02)00332-710.1016/S0720-048X(02)00332-7 ↗
6. 10.1038/3502522010.1038/35025220 ↗
7. 10.1016/j.tibtech.2005.11.00610.1016/j.tibtech.2005.11.006 ↗
8. Shelley S. A. · Chem. Eng. Prog. · 2006 · 102 · 43
9. 10.1016/j.copbio.2004.11.00110.1016/j.copbio.2004.11.001 ↗
10. Suzuki M. · Brain Tumour Pathology · 1996 · 13 · 127
11. 10.1002/mrm.1040610.1002/mrm.10406 ↗
12. 10.1002/mrm.1046510.1002/mrm.10465 ↗
13. 10.1096/fj.04-2026fje10.1096/fj.04-2026fje ↗
14. 10.1016/j.mri.2004.01.05010.1016/j.mri.2004.01.050 ↗
15. 10.1021/ja052337c10.1021/ja052337c ↗
16. 10.1158/0008-5472.CAN-03-323010.1158/0008-5472.CAN-03-3230 ↗
17. 10.1088/0957-4484/17/5/00410.1088/0957-4484/17/5/004 ↗
18. 10.1021/cm051646z10.1021/cm051646z ↗
19. Mornet S. · Eur. Cells Mater. · 2002 · 3 · 110
20. 10.1016/j.biomaterials.2005.02.02010.1016/j.biomaterials.2005.02.020 ↗
21. 10.1016/j.jmmm.2004.02.02010.1016/j.jmmm.2004.02.020 ↗
22. 10.1016/S0304-8853(02)00018-510.1016/S0304-8853(02)00018-5 ↗
23. 10.1006/jcis.1996.006210.1006/jcis.1996.0062 ↗
24. 10.1002/nbm.92410.1002/nbm.924 ↗
25. K. B. Saebo Ph.D. Thesis Uppsala University Sweden2004.
26. 10.1016/S1369-7021(05)71033-610.1016/S1369-7021(05)71033-6 ↗
27. 10.1007/s00269005012210.1007/s002690050122 ↗
28. 10.1016/j.msec.2003.09.15910.1016/j.msec.2003.09.159 ↗
29. 10.1016/j.elspec.2005.10.00110.1016/j.elspec.2005.10.001 ↗
30. 10.1016/j.colsurfa.2005.04.04510.1016/j.colsurfa.2005.04.045 ↗
31. 10.1016/j.colsurfa.2005.04.00910.1016/j.colsurfa.2005.04.009 ↗
32. 10.1016/j.micromeso.2004.04.00810.1016/j.micromeso.2004.04.008 ↗
33. 10.1021/cm020301310.1021/cm0203013 ↗
34. Covalent coupling. Bangs Laboratories Inc. TechNote 205. Rev. 003. 5 2002www.bangslabs.com(accessed March 2007).